Achieve Life Sciences
Clinical trials sponsored by Achieve Life Sciences, explained in plain language.
-
Year-Long test for Quit-Smoking Pill's safety
Disease control CompletedThis study aimed to check the long-term safety of a medication called cytisinicline, taken three times a day for a full year, to help people stop smoking cigarettes or vaping. It involved 479 people in the United States who had previously been in related studies and wanted to qui…
Phase: PHASE3 • Sponsor: Achieve Life Sciences • Aim: Disease control
Last updated Apr 01, 2026 14:50 UTC
-
New Quit-Smoking pill shows promise in major trial
Disease control CompletedThis study tested whether a medication called cytisinicline could help adult smokers quit. Over 800 participants who smoked at least 10 cigarettes a day and wanted to quit were randomly assigned to receive either the real medication or a placebo (a dummy pill) for either 6 or 12 …
Phase: PHASE3 • Sponsor: Achieve Life Sciences • Aim: Disease control
Last updated Mar 25, 2026 14:07 UTC
-
New Quit-Smoking pill shows promise in major trial
Disease control CompletedThis study tested whether a medication called cytisinicline could help adults quit smoking. Nearly 800 daily smokers who had previously tried to quit took either the medication or a placebo pill for 6 or 12 weeks, along with behavioral support. Researchers measured how many peopl…
Phase: PHASE3 • Sponsor: Achieve Life Sciences • Aim: Disease control
Last updated Mar 09, 2026 14:26 UTC
-
New pill tested to break vaping addiction
Disease control CompletedThis study tested whether a medication called cytisinicline could help adults quit using nicotine e-cigarettes. 160 daily vapers were randomly assigned to receive either the real drug or a placebo pill for 12 weeks, along with behavioral support. The main goal was to see if the m…
Phase: PHASE2 • Sponsor: Achieve Life Sciences • Aim: Disease control
Last updated Feb 27, 2026 15:17 UTC